InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by MAIDA ANTHONY E III, Directeur Clinique. Insider active across 1 companies, notably Oncotelic Therapeutics, Inc.. In total, 2 disclosures have been logged. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
938,646 shares
Common Stock
SEC:0001493152-21-017107·
938,646 shares
Common Stock
SEC:0001493152-21-017107:0·
2 of 2 declarations
About MAIDA ANTHONY E III
Anthony E. Maida III is the Chief Clinical Officer at Oncotelic Therapeutics, Inc. In this role, he oversees the company's clinical initiatives, focusing on the development of innovative treatments. Maida is responsible for clinical direction and strategy formulation for clinical trials. His expertise in the healthcare field is essential for the success of Oncotelic Therapeutics.
